GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngene International Ltd (NSE:SYNGENE) » Definitions » 3-Year FCF Growth Rate

Syngene International (NSE:SYNGENE) 3-Year FCF Growth Rate : 27.60% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syngene International 3-Year FCF Growth Rate?

Syngene International's Free Cash Flow per Share for the three months ended in Mar. 2024 was ₹0.00.

During the past 12 months, Syngene International's average Free Cash Flow per Share Growth Rate was 74.80% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 27.60% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 65.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Syngene International was 106.90% per year. The lowest was -34.60% per year. And the median was 28.80% per year.


Competitive Comparison of Syngene International's 3-Year FCF Growth Rate

For the Biotechnology subindustry, Syngene International's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngene International's 3-Year FCF Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngene International's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Syngene International's 3-Year FCF Growth Rate falls into.



Syngene International 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Syngene International  (NSE:SYNGENE) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Syngene International 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Syngene International's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngene International (NSE:SYNGENE) Business Description

Traded in Other Exchanges
Address
Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International (NSE:SYNGENE) Headlines

No Headlines